Perfil espacial y epidemiológico de la COVID-19 en la región Norte del Brasil entre los años 2020 a 2022

Autores/as

DOI:

https://doi.org/10.33448/rsd-v13i1.44726

Palabras clave:

COVID-19; Pandemia; Región norte de Brasil; Perfil epidemiológico y espacial.

Resumen

Objetivo: Analizar los datos de COVID-19 en la región norte de Brasil de 2020 a 2022. Métodos: Se realizó un estudio descriptivo-analítico retrospectivo transversal, utilizando datos digitales epidemiológicos y documentales recopilados entre 2020 y 2022. Resultados: El análisis de la distribución y ocupación de camas hospitalarias, la disponibilidad y distribución de ventiladores y la distribución de medicamentos utilizados para el tratamiento de COVID-19 permitió la evaluación de la efectividad de las políticas de salud implementadas por los gobiernos estatales y municipales durante la pandemia en la región norte de Brasil. El estudio mostró una tendencia a la disminución de la ocupación de camas hospitalarias, posiblemente debido al aumento de la disponibilidad, las medidas de prevención y la vacunación masiva de la población. Sin embargo, destacó la necesidad de un sistema de atención médica de calidad con recursos adecuados y profesionales de la salud capacitados para mejorar la respuesta a la pandemia. Conclusión: El análisis integrado de los datos sobre COVID-19 en la región norte de Brasil proporcionó una visión general de la pandemia e identificó posibles deficiencias en la respuesta a la misma. Este estudio destaca la necesidad de políticas de salud efectivas y equitativas, la asignación de recursos y la adaptación de las estrategias de tratamento basadas en la evolución del conocimiento científico de COVID-19 y sus variantes.

Citas

Almeida, J. B., et al. (2020). Oxygen shortage crisis in Manaus during the COVID-19 pandemic: Perspectives from healthcare workers. Journal of Health Management, 18(2), 157-172.

Axfors, C., Schmitt, A. M., & Janiaud, P. (2021). Chloroquine for COVID-19: What do we know? Clinical Microbiology and Infection, 27(1), 9-12.

Berlin, D. A., Gulick, R. M., & Martinez, F. J. (2020). Severe COVID-19. New England Journal of Medicine, 383(25), 2451-2460.

Brasil, Ministério da Saúde. (2020). Protocolo de Manejo Clínico da COVID-19 1a edição revisada. Retrieved from https://bvsms.saude.gov.br/bvs/publicacoes/manejo_clinico_COVID-19 _atencao_especializada.pdf

Brasil, Ministério da Saúde. (2021, Apr 8). O Que É a COVID-19? Retrieved from https://www.gov.br/saude/pt-br/coronavirus/o-que-e-o-coronavirus

Chag, K., et al. (2021). COVID-19 vaccination: Impact on hospitalizations and mortality. medRxiv.

Chinazzi, M., Davis, J. T., Ajelli, M., Gioannini, C., Litvinova, M., Merler, S., & Viboud, C. (2020). The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science, 368(6489), 395-400.

Clark, A., et al. (2020). Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: A modelling study. The Lancet Global Health, 8(8), e1003-e1017.

Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., & Uriel, N. (2020). COVID-19 and cardiovascular disease. Circulation, 141(20), 1648-1655.

Domingues, C. M. A. S. (2023). Desafios para a realização da campanha de vacinação contra a COVID-19 no Brasil. Cadernos de Saúde Pública, 37.

Ferguson, N. M., Laydon, D., Nedjati-Gilani, G., Imai, N., Ainslie, K., Baguelin, M., & Dighe, A. (2020). Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College COVID-19 Response Team.

Fio Cruz. (2022). Processo saúde-doença [Internet]. Determinantes Sociais da Saúde. Retrieved from https://dssbr.ensp.fiocruz.br/glossary/processo-saude-doenca/

Fontanet, A., et al. (2021). SARS-CoV-2 variants and ending the COVID-19 pandemic. The Lancet Infectious Diseases, 21(6), e195-e196.

Freitas, A. R. R., Napimoga, M., & Donalisio, M. R. (2020). Assessing the severity of COVID-19. Epidemiologia e Serviços de Saúde, 29(2).

Fleury, S., & Fava, V. M. D. (2022). Vacina contra COVID-19: arena da disputa federativa brasileira. Saúde em Debate, 46, 248-264.

Gatto, M., Bertuzzo, E., Mari, L., Miccoli, S., Carraro, L., Casagrandi, R., & Rinaldo, A. (2020). Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures. Proceedings of the National Academy of Sciences, 117(19), 10484-10491.

Gonçalves, C. W. B., et al. (2020). Incidence of COVID-19 in the states of the northern region of Brazil. Revista de Prevenção da Infecção e Saúde, 6.

Grasselli, G., et al. (2020). Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA, 323(16), 1574-1581.

Guan, W.J., et al. (2020). Comorbidity and its impact on 1590 patients with COVID-19 in China: A Nationwide Analysis. European Respiratory Journal, 55(5), 2000547.

Hallal, P. C., Hartwig, F. P., Horta, B. L., Silveira, M. F., Struchiner, C. J., Vidaletti, L. P., & Barros, F. C. (2020). SARS-CoV-2 antibody prevalence in Brazil: Results from two successive nationwide serological household surveys. The Lancet Global Health, 8(11), e1390-e1398.

Harrison, S. L., Fazio-Eynullayeva, E., Lane, D. A., Underhill, P., & Lip, G. Y. H. (2020). Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis. PLoS Medicine, 17(9), e1003321.

Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., & Consortium, C.-G. U. (2021). SARS-CoV-2 variants, spike mutations and immune escape. Nature Reviews Microbiology, 19(7), 409-424.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497-506.

IBGE. (2021). Regiões de planejamento e regiões metropolitanas. Instituto Brasileiro de Geografia e Estatística. Recuperado em 21 de abril de 2023, de https://www.ibge.gov.br/geociencias-novoportal/cartas-e-mapas/redes-geograficas/15778-regioes-de-planejamento-e-regioes-metropolitanas.html?=&t=o-que-e.

Jin, J. M., et al. (2020). Gender differences in patients with COVID-19: Focus on severity and mortality. Frontiers in Public Health, 8, 152.

Kandel, N., Chungong, S., Omaar, A., & Xing, J. (2020). Health security capacities in the context of COVID-19 outbreak: An analysis of International Health Regulations annual report data from 182 countries. The Lancet, 395(10229), 1047-1053.

Kraemer, M. U., et al. (2020). The effect of human mobility and control measures on the COVID-19 epidemic in China. Science, 368(6490), 493-497.

Lima, M. S. (2021). The oxygen crisis in Manaus: Lessons learned and the need for preparedness. Revista Brasileira de Terapia Intensiva, 33(3), 365-371.

MacDonald, N. E., et al. (2021). COVID-19 and vaccination: A review of the ongoing development and the role of public health in promoting vaccination. Vaccine, 39(6), 900-911.

Majumder, M. S., & Mandl, K. D. (2020). Early in the epidemic: Impact of preprints on global discourse about COVID-19 transmissibility. The Lancet Global Health, 8(5), e627-e630.

Malta, D. C., Szwarcwald, C. L., Barros, M. B. D. A., Gomes, C. S., Machado, Í. E., Souza Júnior, P. R. B. D., & Gracie, R. (2020). A pandemia da COVID-19 e as mudanças no estilo de vida dos brasileiros adultos: um estudo transversal, 2020. Epidemiologia e Serviços de Saúde, 29(4), e2020407.

O'Driscoll, M., et al. (2021). Age-specific mortality and immunity patterns of SARS-CoV-2. Nature, 590(7844), 140-145.

Oliveira, F. A. (2022). Assessing the effectiveness of vaccination strategies in controlling COVID-19: A case study of Manaus, Belém, and Santarém. Journal of Public Health Management and Practice, 28(1), 45-57.

Peckham, H., et al. (2020). Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nature Communications, 11(1), 1-10.

Peeling, R. W., Wedderburn, C. J., Garcia, P. J., Boeras, D., Fongwen, N., Nkengasong, J., ... & Mabey, D. (2020). Serology testing in the COVID-19 pandemic response. The Lancet Infectious Diseases, 20(9), e245-e249.

Rocha, P. L., & Pereira, V. S. (2022). Analysis of medication expenditures and its correlation with COVID-19 case fatality rate: A case study of Manaus. Health Economics and Outcomes Research, 12(3), 245-259.

Santos, J. C., & Costa, M. F. (2022). Impact of oxygen supply shortage on COVID-19 patient outcomes in Manaus. Journal of Clinical Medicine Research, 14(2), 87-96.

Santos, R. M., et al. (2021). Impact of vaccination on COVID-19 cases and deaths in Manaus, Belém, and Santarém: A retrospective analysis. Brazilian Journal of Infectious Diseases, 15(4), 312-328.

Silva, A. B., & Souza, C. D. (2020). Vaccine effectiveness and COVID-19 recovery in Manaus, Belém, and Santarém: A comparative study. Journal of Epidemiology and Public Health, 8(2), 120-135.

Silva Filho, P. S., de Sousa Silva, M. J., Júnior, E. J. F., Rocha, M. M. L., Araujo, I. A., de Carvalho, I. C. S., & Mesquita, G. V. (2023). Vacinas contra Coronavírus (COVID-19; SARS-COV-2) no Brasil: um panorama geral. Research, society and development, 10(8), e26310817189-e26310817189.

Ventola, C. L. (2015). The antibiotic resistance crisis: Part 1: Causes and threats. Pharmacy and Therapeutics, 40(4), 277-283.

WHO. (2020). "Solidarity" clinical trial for COVID-19 treatments. World Health Organization. https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON-18june2020-who

WHO. (2021). Clinical management of COVID-19: Interim guidance, 25 January 2021. World Health Organization. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1

Wilder-Smith, A., Freedman, D. O., & Vannice, K. (2020). Challenges in public health responses to COVID-19 in rural America. The Lancet Infectious Diseases, 20(10), 1103-1104.

Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., & Schultze, A. (2020). Factors associated with COVID-19 -related death using OpenSAFELY. Nature, 584(7821), 430-436.

Wirtz, V. J., Hogerzeil, H. V., Gray, A. L., Bigdeli, M., de Joncheere, C. P., Ewen, M. A., & Laing, R. O. (2017). Essential medicines for universal health coverage. The Lancet, 389(10067), 403-476.

Wu, C., et al. (2020). Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Medicine, 180(7), 934-943.

Zhou, F., et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet, 395(10229), 1054-1062.

Publicado

10/01/2024

Cómo citar

BARBOSA, E. M. .; RUSSILLO, E. da R. .; SILVA, E. S. C. da .; ANDRADE, H. C. Q. .; GUIMARÂES, H. S. .; PEIXOTO, I. C. de S. .; BRABO, R. C. .; RODRIGUES, T. de A. .; ROSENDO, T. de O. .; RODRIGUES, M. H. C. . Perfil espacial y epidemiológico de la COVID-19 en la región Norte del Brasil entre los años 2020 a 2022. Research, Society and Development, [S. l.], v. 13, n. 1, p. e4313144726, 2024. DOI: 10.33448/rsd-v13i1.44726. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/44726. Acesso em: 17 jun. 2024.

Número

Sección

Ciencias de la salud